The Pelvic Medicine Centre, St Andrew's War Memorial Hospital
Brisbane, Australia
Location status: Recruiting
NCT Number: NCT07467837
PRIME Mothers is a national observational trial designed to evaluate patient outcomes with Stratamark® for the prevention of stretch marks during pregnancy and the postpartum period. The study is designed to fit seamlessly into routine clinical practice, with digital follow-up and home resupply, minimising clinic involvement.
Interested in participating?
Request Info18 year and older
Female
Observational
Brisbane, Australia
Location status: Recruiting
Pregnant women visiting the healthcare professional will have the opportunity to participate in the study by scanning a QR code displayed at the healthcare professional office. Upon scanning the QR code, participants will be directed to complete an electronic informed consent form, followed by a baseline self-assessment. Eligibility will be automatically determined based on the information provided during this assessment. As part of the baseline self-assessment, participants will submit demographic information and confirm the absence of any pre-existing stretch marks on their abdomen. Eligible participants will then receive a confirmation notification indicating their enrollment in the study. This notification must be presented to the healthcare professional to receive the initial supply (two tubes of 50g Stratamark®) of the study product from the healthcare professionals office
Monthly follow-up self-assessments will be performed remotely using an electronic Case Report Form (eCRF) tool. Participants will receive a link to access and complete the survey online, this includes the option to provide photographs (abdomen only).
If a participant requires resupply of the study product, completion of at least one monthly follow-up self-assessment is required. Upon completion, the participant will receive a confirmation notification containing a code and a link to order the next product supply free of charge.
The final assessment will take place 6-8 weeks after the baby has been delivered.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Topical film-forming silicone gel
Time frame: From enrolment until 6-8 weeks postpartum
The proportion of participants who develop new stretch marks during pregnancy and up to the postpartum period, as assessed by monthly self-reports completed by the participant. The patient reports whether stretch marks have developed by answering yes/no (binary scale).
Time frame: From enrolment until 6-8 weeks postpartum
Tracking participants' adherence to the recommended usage regimen. % Adherence over time measured on a continuous scale from 0-100%, where 100% is better than 0%. Minimum adherence being 0 days and maximum being 7 days.
Contact information is provided by the study sponsor or research team.
Stratpharma AG
Industry
Prevention (Reduction of Incidence) of Stretch Marks in Expectant Mothers
Acronym: PRIME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07413393
Intervention, Knowledge
Valencia, Spain
View Trial DetailsNCT04964206
Agnosia, Analgesia, Epidural
Beijing, Beijing Municipality, China
View Trial DetailsNCT06575309
Pregnant Women, Venous Thromboembolic Disease
Clermont-Ferrand, France
View Trial DetailsNCT05358834
Pregnant Women
Boston, Massachusetts, United States
View Trial Details